指南与共识银屑病与炎症性皮肤病湿疹皮炎与荨麻疹药疹与重症皮肤不良反应

化脓性汗腺炎共病筛查:美加基金会循证推荐

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
指南 / 共识 · J Am Acad Dermatol · 2021-01-23

该指南由美国与加拿大化脓性汗腺炎基金会制定,基于系统综述总结30种共病在HS患者中的患病率与发病率,采用SORT标准分级证据与推荐强度,建议对痤疮、抑郁、肥胖、糖尿病、心血管疾病等多种共病进行筛查,并建议对唐氏综合征患者筛查HS。

要点

  • 推荐筛查的共病包括痤疮、抑郁、焦虑、自杀、肥胖、糖尿病、高血压、心血管疾病等。
  • 建议对唐氏综合征患者进行HS筛查。
  • 筛查决策应结合患者风险因素,皮肤科医生的角色因共病而异。

核心结论

  • 皮肤科医生应支持筛查HS患者的共病,以识别相关疾病。

研究设计与样本

  • 基于系统综述总结30种共病在HS患者中相对一般人群的患病率与发病率,采用SORT标准分级证据与推荐强度。

主要发现

  • 系统综述总结了30种共病在HS患者中的患病率与发病率。
  • 筛查推荐基于研究一致性、质量、疾病患病率、关联强度及筛查利弊与可行性。

关键数值与推荐

  • 推荐筛查的共病包括:痤疮、头皮分割性蜂窝织炎、藏毛疾病、坏疽性脓皮病、抑郁、广泛性焦虑障碍、自杀、吸烟、物质使用障碍、多囊卵巢综合征、肥胖、血脂异常、糖尿病、代谢综合征、高血压、心血管疾病、炎症性肠病、脊柱关节炎、性功能障碍。
  • 建议对唐氏综合征患者筛查HS。
  • 具体共病筛查决策可能因患者风险因素而异。

临床怎么用

  • 皮肤科医生应根据共病类型在筛查中发挥相应作用,并支持筛查工作。

局限性

  • 筛查推荐仅为综合护理策略的一部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hidradenitis suppurativa (HS) is associated with comorbidities that contribute to poor health, impaired life quality, and mortality risk. OBJECTIVE: To provide evidence-based screening recommendations for comorbidities linked to HS. METHODS: Systematic reviews were performed to summarize evidence on the prevalence and incidence of 30 comorbidities in patients with HS relative to the general population. The screening recommendation for each comorbidity was informed by the consistency and quality of existing studies, disease prevalence, and magnitude of association, as well as benefits, harms, and feasibility of screening. The level of evidence and strength of corresponding screening recommendation were graded by using the Strength of Recommendation Taxonomy (SORT) criteria. RESULTS: Screening is recommended for the following comorbidities: acne, dissecting cellulitis of the scalp, pilonidal disease, pyoderma gangrenosum, depression, generalized anxiety disorder, suicide, smoking, substance use disorder, polycystic ovary syndrome, obesity, dyslipidemia, diabetes mellitus, metabolic syndrome, hypertension, cardiovascular disease, inflammatory bowel disease, spondyloarthritis, and sexual dysfunction. It is also recommended to screen patients with Down syndrome for HS. The decision to screen for specific comorbidities may vary with patient risk factors. The role of the dermatologist in screening varies according to comorbidity. LIMITATIONS: Screening recommendations represent one component of a comprehensive care strategy. CONCLUSIONS: Dermatologists should support screening efforts to identify comorbid conditions in HS.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Garg A, Malviya N, Strunk A, et al. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2021. PMID: 33493574. doi:10.1016/j.jaad.2021.01.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。